{"id":1057,"date":"2017-05-10T12:39:58","date_gmt":"2017-05-10T10:39:58","guid":{"rendered":"http:\/\/www.pharmin.sk\/?p=1057"},"modified":"2018-11-16T10:35:36","modified_gmt":"2018-11-16T09:35:36","slug":"nova-publikacia-vyuzivanie-vybranej-zdravotnej-starostlivosti-pri-pacientoch-s-karcinomom-pluc-v-sr","status":"publish","type":"post","link":"https:\/\/www.pharmin.sk\/sk\/aktuality\/nova-publikacia-vyuzivanie-vybranej-zdravotnej-starostlivosti-pri-pacientoch-s-karcinomom-pluc-v-sr\/","title":{"rendered":"NOV\u00c1 PUBLIK\u00c1CIA: Vyu\u017e\u00edvanie vybranej zdravotnej starostlivosti pri pacientoch s karcin\u00f3mom p\u013e\u00fac v SR"},"content":{"rendered":"

Autori: Ondru\u0161ov\u00e1, M., Ber\u017einec, P., Suchansk\u00fd, M.<\/p>\n

Predkladan\u00e1 recenzovan\u00e1 elektronick\u00e1 publik\u00e1cia sumarizuje v\u00fdsledky kvalitat\u00edvneho prierezov\u00e9ho prieskumu \u00a0o vyu\u017e\u00edvan\u00ed vybranej zdravotnej starostlivosti\u00a0pri mana\u017emente pacientov s pokro\u010dil\u00fdm a metastatick\u00fdm prim\u00e1rnym adenokarcin\u00f3mom, skvamocelul\u00e1rnym a malobunkov\u00fdm karcin\u00f3mom p\u013e\u00fac na Slovensku. Na prieskume sa z\u00fa\u010dastnilo 29 respondentov – onkol\u00f3gov so sk\u00fasenos\u0165ami v lie\u010dbe karcin\u00f3mu p\u013e\u00fac. Vyzbieran\u00e1 vzorka dispenzarizovan\u00fdch pacientov bez oh\u013eadu na histologicky typ a klinick\u00e9 \u0161t\u00e1dium predstavovala 2 806 pacientov. V\u00fdstupn\u00e9 anal\u00fdzy zah\u0155\u0148aj\u00fa region\u00e1lne charakteristiky, zvyklosti respondentov pri testovan\u00ed EGFR\/ALK, rozdelenia dispenzarizovan\u00fdch pacientov do klinick\u00fdch \u0161t\u00e1di\u00ed a pod\u0161t\u00e1di\u00ed pod\u013ea histologick\u00fdch typov, ECOG sk\u00f3re pod\u013ea histologick\u00fdch typov, aktu\u00e1lny \u201emarket share\u201c pod\u013ea histologick\u00fdch typov a pod. V\u00fdstupy boli spracovan\u00e9 met\u00f3dami deskript\u00edvnej \u0161tatistiky. Report je plne citovate\u013en\u00fd s renomovan\u00fdmi spoluautormi, recenzovan\u00fd odborn\u00edkom z pr\u00edslu\u0161nej oblasti (vyjadrenie recenzenta tvor\u00ed pr\u00edlohu reportu), s pridelen\u00fdm vlastn\u00fdm ISBN k\u00f3dom, obsahuje 27 str\u00e1n preh\u013eadn\u00fdch v\u00fdpo\u010dtov, tabuliek, grafov a podrobn\u00fdch popisov v\u0161etk\u00fdch anal\u00fdz a zisten\u00fdch v\u00fdsledkov.<\/p>\n

V pr\u00edpade \u017ee m\u00e1te z\u00e1ujem o zak\u00fapenie publik\u00e1cie, alebo ak potrebujete bli\u017e\u0161ie inform\u00e1cie,\u00a0kontaktujte n\u00e1s<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

Autori: Ondru\u0161ov\u00e1, M., Ber\u017einec, P., Suchansk\u00fd, M. Predkladan\u00e1 recenzovan\u00e1 elektronick\u00e1 publik\u00e1cia sumarizuje v\u00fdsledky kvalitat\u00edvneho prierezov\u00e9ho prieskumu \u00a0o vyu\u017e\u00edvan\u00ed vybranej zdravotnej starostlivosti\u00a0pri mana\u017emente pacientov s pokro\u010dil\u00fdm a metastatick\u00fdm prim\u00e1rnym adenokarcin\u00f3mom, skvamocelul\u00e1rnym a malobunkov\u00fdm karcin\u00f3mom p\u013e\u00fac na Slovensku. Na prieskume sa z\u00fa\u010dastnilo 29 respondentov – onkol\u00f3gov so sk\u00fasenos\u0165ami v lie\u010dbe karcin\u00f3mu p\u013e\u00fac. Vyzbieran\u00e1 vzorka dispenzarizovan\u00fdch pacientov bez<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-1057","post","type-post","status-publish","format-standard","hentry","category-aktuality"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts\/1057","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/comments?post=1057"}],"version-history":[{"count":0,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/posts\/1057\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/media?parent=1057"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/categories?post=1057"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pharmin.sk\/sk\/wp-json\/wp\/v2\/tags?post=1057"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}